Literature DB >> 8666691

Expression of Epstein-Barr virus encoded latent genes in nasal T cell lymphomas.

J van Gorp1, A Brink, J J Oudejans, A J van den Brule, J G van den Tweel, N M Jiwa, P C de Bruin, C J Meijer.   

Abstract

AIMS: To determine the expression of Epstein-Barr (EB) virus encoded latent genes in nasal T-cell lymphomas in The Netherlands.
METHODS: Seven europid (Dutch) cases of nasal T cell lymphoma were investigated for the presence of EB virus by RNA in situ hybridisation (EBER). The expression of the EB virus encoded genes BARF0, EBNA1, EBNA2, LMP1, LMP2A, LMP2B, and ZEBRA was studied at the mRNA level using reverse transcriptase polymerase chain reaction. At the protein level the expression was investigated of EBNA2 and LMP1 by immunohistochemistry.
RESULTS: In all seven nasal T cell lymphomas EBER was detected in the nuclei of virtually all tumour cells. BARF0 mRNA was detected in all samples. EBNA1 mRNA was found in six cases, LMP1 mRNA in five, LMP2A mRNA in three, LMP2B mRNA in one, and ZEBRA mRNA in one. EBNA2 mRNA was not found in any case. At the protein level occasional LMP1 positive tumour cells were seen in only one case. The EBNA2 protein was not detected.
CONCLUSIONS: Nasal T cell lymphomas in The Netherlands are strongly associated with EB virus. The virus shows a type II latency pattern (EBNA1+, LMP1+, EBNA2-) that seems to be similar to the EB virus associated nasal T cell lymphomas in oriental countries.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8666691      PMCID: PMC1023162          DOI: 10.1136/jcp.49.1.72

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  32 in total

1.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

Authors:  J I Cohen; F Wang; J Mannick; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

2.  Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma.

Authors:  Y Harabuchi; N Yamanaka; A Kataura; S Imai; T Kinoshita; F Mizuno; T Osato
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

3.  Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.

Authors:  L Young; C Alfieri; K Hennessy; H Evans; C O'Hara; K C Anderson; J Ritz; R S Shapiro; A Rickinson; E Kieff
Journal:  N Engl J Med       Date:  1989-10-19       Impact factor: 91.245

4.  Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells.

Authors:  E Grogan; H Jenson; J Countryman; L Heston; L Gradoville; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

5.  Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLF1 plasmids.

Authors:  L Gradoville; E Grogan; N Taylor; G Miller
Journal:  Virology       Date:  1990-10       Impact factor: 3.616

6.  Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.

Authors:  G Pallesen; S J Hamilton-Dutoit; M Rowe; L S Young
Journal:  Lancet       Date:  1991-02-09       Impact factor: 79.321

7.  Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.

Authors:  R Fåhraeus; H L Fu; I Ernberg; J Finke; M Rowe; G Klein; K Falk; E Nilsson; M Yadav; P Busson
Journal:  Int J Cancer       Date:  1988-09-15       Impact factor: 7.396

8.  Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases.

Authors:  J Van Gorp; P C De Bruin; D M Sie-Go; P Van Heerde; G J Ossenkoppele; L H Rademakers; C J Meijer; J G Van Den Tweel
Journal:  Histopathology       Date:  1995-08       Impact factor: 5.087

9.  Epstein-Barr virus gene expression in nasopharyngeal carcinoma.

Authors:  L S Young; C W Dawson; D Clark; H Rupani; P Busson; T Tursz; A Johnson; A B Rickinson
Journal:  J Gen Virol       Date:  1988-05       Impact factor: 3.891

10.  Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type.

Authors:  F C Ho; G Srivastava; S L Loke; K H Fu; B P Leung; R Liang; D Choy
Journal:  Hematol Oncol       Date:  1990 Sep-Oct       Impact factor: 5.271

View more
  9 in total

1.  Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma.

Authors:  Masayoshi Nagamine; Miki Takahara; Kan Kishibe; Toshihiro Nagato; Hideyuki Ishii; Nobuyuki Bandoh; Takeshi Ogino; Yasuaki Harabuchi
Journal:  Virus Genes       Date:  2006-08-18       Impact factor: 2.332

2.  Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome.

Authors:  Huai-Chia Chuang; Jong-Ding Lay; Shuang-En Chuang; Wen-Chuan Hsieh; Yao Chang; Ih-Jen Su
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

Review 3.  Emerging insights on the pathogenesis and treatment of extranodal NK/T cell lymphomas (ENKTL).

Authors:  Bradley M Haverkos; Carrie Coleman; Alejandro A Gru; Zenggang Pan; Jonathan Brammer; Rosemary Rochford; Anjali Mishra; Christopher C Oakes; Robert A Baiocchi; Aharon G Freud; Pierluigi Porcu
Journal:  Discov Med       Date:  2017-03       Impact factor: 2.970

4.  Expression of Epstein-Barr virus (EBV) transcripts encoding homologues to important human proteins in diverse EBV associated diseases.

Authors:  D P Hayes; A A Brink; M B Vervoort; J M Middeldorp; C J Meijer; A J van den Brule
Journal:  Mol Pathol       Date:  1999-04

5.  Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors.

Authors:  G J Babcock; D A Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 6.  Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.

Authors:  Lindsay C George; Martin Rowe; Christopher P Fox
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

7.  Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.

Authors:  Ilona Argirion; Katie R Zarins; Julie J Ruterbusch; Patravoot Vatanasapt; Hutcha Sriplung; Erlene K Seymour; Laura S Rozek
Journal:  Cancer       Date:  2019-09-16       Impact factor: 6.860

8.  A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.

Authors:  Midori Ando; Yasuharu Sato; Katsuyoshi Takata; Junko Nomoto; Shigeo Nakamura; Koichi Ohshima; Tamotsu Takeuchi; Yorihisa Orita; Yukio Kobayashi; Tadashi Yoshino
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations.

Authors:  Christopher P Fox; Claire Shannon-Lowe; Martin Rowe
Journal:  Herpesviridae       Date:  2011-09-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.